We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
58 hedge funds and large institutions have $44.4M invested in CASI Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
40% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 15
9% more funds holding
Funds holding: 53 → 58 (+5)
0.07% more ownership
Funds ownership: 2.12% → 2.2% (+0.07%)
30% less capital invested
Capital invested by funds: $63.2M → $44.4M (-$18.8M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
58
Holders Change
+5
Holders Change %
+9.43%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
21
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$2.48M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$344K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$332K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$120K |
| 5 |
WSC
Wellington Shields & Co
New York
|
+$91.3K |
Top Sellers
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$213K |
| 2 |
Morgan Stanley
New York
|
-$153K |
| 3 |
State Street
Boston,
Massachusetts
|
-$103K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$89.3K |
| 5 |
Barclays
London,
United Kingdom
|
-$80.6K |
